Anacor Pharma (ANAC) Tops Q4 EPS by 37c

Anacor Pharma (NASDAQ: ANAC) reported Q4 EPS of ($0.24), $0.37 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $9.6 million, versus $8.4 million reported last year.

For earnings history and earnings-related data on Anacor Pharma (ANAC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c